126 related articles for article (PubMed ID: 9276623)
1. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine.
Lane KE; Leav I; Ziar J; Bridges RS; Rand WM; Ho SM
Carcinogenesis; 1997 Aug; 18(8):1505-10. PubMed ID: 9276623
[TBL] [Abstract][Full Text] [Related]
2. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780.
Thompson CJ; Tam NN; Joyce JM; Leav I; Ho SM
Endocrinology; 2002 Jun; 143(6):2093-105. PubMed ID: 12021174
[TBL] [Abstract][Full Text] [Related]
4. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
Ho SM; Yu M
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144
[TBL] [Abstract][Full Text] [Related]
5. Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia.
Tam NN; Szeto CY; Freudenberg JM; Fullenkamp AN; Medvedovic M; Ho SM
Mol Endocrinol; 2010 Nov; 24(11):2207-17. PubMed ID: 20861223
[TBL] [Abstract][Full Text] [Related]
6. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
7. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
Ofner P; Bosland MC; Vena RL
Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
[TBL] [Abstract][Full Text] [Related]
9. Rat estrogen receptor-alpha and -beta, and progesterone receptor mRNA expression in various prostatic lobes and microdissected normal and dysplastic epithelial tissues of the Noble rats.
Lau KM; Leav I; Ho SM
Endocrinology; 1998 Jan; 139(1):424-7. PubMed ID: 9421443
[TBL] [Abstract][Full Text] [Related]
10. The role of prolactin in the prostatic inflammatory response to neonatal estrogen.
Gilleran JP; Putz O; DeJong M; DeJong S; Birch L; Pu Y; Huang L; Prins GS
Endocrinology; 2003 May; 144(5):2046-54. PubMed ID: 12697713
[TBL] [Abstract][Full Text] [Related]
11. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats.
Leav I; Ho SM; Ofner P; Merk FB; Kwan PW; Damassa D
J Natl Cancer Inst; 1988 Sep; 80(13):1045-53. PubMed ID: 2457709
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.
Ho SM; Leav I; Ghatak S; Merk F; Jagannathan VS; Mallery K
Am J Pathol; 1998 Jul; 153(1):131-9. PubMed ID: 9665473
[TBL] [Abstract][Full Text] [Related]
13. L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats.
Özten N; Schlicht M; Diamond AM; Bosland MC
Nutr Cancer; 2014; 66(5):825-34. PubMed ID: 24773027
[TBL] [Abstract][Full Text] [Related]
14. Prolactin (PRL) regulation of maternal behavior in rats: bromocriptine treatment delays and PRL promotes the rapid onset of behavior.
Bridges RS; Ronsheim PM
Endocrinology; 1990 Feb; 126(2):837-48. PubMed ID: 2298174
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats.
Ho SM; Roy D
Cancer Lett; 1994 Sep; 84(2):155-62. PubMed ID: 8076372
[TBL] [Abstract][Full Text] [Related]
16. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate.
Kaplan PJ; Leav I; Greenwood J; Kwan PW; Ho SM
Carcinogenesis; 1996 Dec; 17(12):2571-9. PubMed ID: 9006091
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats.
Lane KE; Ricci MJ; Ho SM
Prostate; 1997 Mar; 30(4):256-62. PubMed ID: 9111603
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of estradiol and estrone in organ cultures of dorsolateral and ventral prostate of untreated and sex hormone-implanted rats.
Ofner P; Nadeau MR; Vena RL; Leav I
Steroids; 1992 Feb; 57(2):50-5. PubMed ID: 1621255
[TBL] [Abstract][Full Text] [Related]
19. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
[TBL] [Abstract][Full Text] [Related]
20. Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase.
Bosland MC; Vega K; Horton L; Schlicht MJ
Prostate; 2023 Jun; 83(9):823-830. PubMed ID: 36938936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
